Resisting resistance to cancer immunotherapy
THORACIC CANCER
Saved in:
Main Authors: | RAGHAV SUNDAR, Lam, W.S.-T., Wang, L.Z., Roudi, R., Yong, W.-P., Syn, N.L. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Editorial |
Language: | English |
Published: |
WILEY
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206998 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Lung Cancer in Singapore
by: Ang, Yvonne LE, et al.
Published: (2022) -
High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547
by: Lau, Wen Min, et al.
Published: (2019) -
Cyclin D1 expression in KRAS mutant non-small cell lung cancer-old wine into new skins
by: Goh, Kah Yee, et al.
Published: (2024) -
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
by: Ma, Jun, et al.
Published: (2024) -
Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Letter
by: Dharmadhikari, Bhushan, et al.
Published: (2023)